Attention-deficit/hyperactivity disorder: A life-span perspective

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 7, 1998, Pages 4-16

  Biederman, Joseph ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CENTRAL STIMULANT AGENT; CLONIDINE; CLORGYLINE; DESIPRAMINE; DEXAMPHETAMINE; FLUOXETINE; GUANFACINE; HYPERTENSIVE FACTOR; IMIPRAMINE; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PARGYLINE; PEMOLINE MAGNESIUM; PHENTOLAMINE MESYLATE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ADULT; ADULT DISEASE; AFFECTIVE NEUROSIS; ANOREXIA; ARTICLE; ATTENTION DEFICIT DISORDER; AUTONOMIC DYSFUNCTION; CHILD; CLINICAL TRIAL; COMORBIDITY; DRUG EFFECT; DRUG EFFICACY; GENDER; GENETIC EPIDEMIOLOGY; GROWTH RETARDATION; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; REMISSION; TIC;

ADOLESCENT; ADULT; AGE FACTORS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BUPROPION; CHILD; COMORBIDITY; DEXTROAMPHETAMINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MENTAL DISORDERS; METHYLPHENIDATE; PEMOLINE; SEX FACTORS;

EID: 0031820777     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (210)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
2. Castellanos F, Giedd J, Eckburg P, et al. Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. Am J Psychiatry 1994;151:1791-1796
3. Hynd GW, Hern KL, Novey ES, et al. Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol 1993;8:339-347
4. Giedd JN, Castellanos FX, Casey BJ, et al. Quantitative morphology of the corpus callosum in attention deficit hyperactivity disorder. Am J Psychiatry 1994;151:665-669
5. Semrud-Clikeman M, Filipek P, Biederman J, et al. Attention deficit disorder: differences in the corpus callosum and shape analysis in MRI morphometric analysis. J Am Acad Child Adolesc Psychiatry 1994;33:875-881
6. Hynd GW, Semrud-Clikeman MS, Lorys AR, et al. Brain morphology in developmental dyslexia and attention deficit/hyperactivity. Arch Neurol 1990;47:919-926
7. Zametkin AJ, Rapoport JL. Noradrenergic hypothesis of attention deficit disorder with hyperactivity: a critical review. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press; 1987:837-842
8. Zametkin AJ, Nordahl TE, Gross M, et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 1990;323: 1361-1366
9. Biederman J, Faraone SV, Keenan K, et al. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder (ADHD): patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 1992;49: 728-738
10. Biederman J, Faraone SV, Keenan K, et al. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1990;29:526-533
11. Goodman R. Genetic factors in hyperactivity: account for about half of the explainable variance. BMJ 1989;298:1407-1408
12. Goodman R, Stevenson J. A twin study of hyperactivity, I: an examination of hyperactivity scores and categories derived from Rutter teacher and parent questionnaires. J Child Psychol Psychiatry 1989;30:671-689
13. Goodman R, Stevenson J. A twin study of hyperactivity, II: the aetiological role of genes, family relationships and perinatal adversity. J Child Psychol Psychiatry 1989;30:691-709
14. Faraone S, Biederman J, Chen WJ, et al. Segregation analysis of attention deficit hyperactivity disorder: evidence for single gene transmission. Psychiatr Genet 1992;2:257-275
15. Faraone S, Biederman J. Is attention deficit hyperactivity disorder familial? Harv Rev Psychiatry 1994;1:271-287
16. Deutsch CK, Matthysse S, Swanson JM, et al. Genetic latent structure analysis of dysmorphology in attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1990;29:189-194
17. Manshadi M, Lippmann S, O'Daniel RG, et al. Alcohol abuse and attention deficit disorder. J Clin Psychiatry 1983;44:379-380
18. Biederman J, Milberger S, Faraone S, et al. Family environmental risk factors for attention deficit hyperactivity disorder: a test of Rutter's indicators of adversity. In: Scientific Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry; October 28, 1994; New York, NY. Abstract No. 701-21
19. Milberger S, Biederman J, Sprich-Buckminster S, et al. Are perinatal complications relevant to the manifestation of attention-deficit hyperactivity disorder? In: Scientific Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry: October 28, 1993; San Antonio, Tex. Abstract No. 700-66
20. Gittelman R, Mannuzza S, Shenker R, et al. Hyperactive boys almost grown up, I: psychiatric status. Arch Gen Psychiatry 1985;42:937-947
21. Hechtman L. Long-term outcome in attention-deficit hyperactivity disorder. Psychiatr Clin North Am 1992;1:553-565
22. Mannuzza S, Klein RG, Bonagura N, et al. Hyperactive boys almost grown up, V: replication of psychiatric status. Arch Gen Psychiatry 1991;48: 77-83
23. Mannuzza S, Klein RG, Bessler A, et al. Adult outcome of hyperactive boys: educational achievement, occupational rank and psychiatric status. Arch Gen Psychiatry 1993;50:565-576
24. Weiss G, Hechtman L, Milroy T, et al. Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry 1985;24:211-220
25. Lahey BB, Pelham WE, Schaughency EA, et al. Dimensions and types of attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1988;27:330-335
26. Bauermeister J, Alegria M, Bird H, et al. Are attention-hyperactivity deficits unidimensional or multidimensionsal syndromes? empirical findings from a community survey. J Am Acad Child Adolesc Psychiatry 1992;31: 423-431
27. Lahey B, Applegate B, McBurnett K, et al. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry 1994;151:1673-1685
28. Paternite CE, Loney J, Roberts MA. A preliminary validation of subtypes of DSM-IV attention-deficit/hyperactivity disorder. Journal of Attention Disorders 1996;1:70-86
29. Morgan A, Hynd G, Riccio C, et al. Validity of DSM-IV ADHD predominantly inattentive and combined types: relationship to previous DSM diagnoses/subtype differences. J Am Acad Child Adolesc Psychiatry 1996;35: 325-333
30. Biederman J, Faraone S, Weber W, et al. Correspondence between DSM-III-R and DSM-IV Attention Deficit Hyperactivity Disorder (ADHD). J Am Acad Child Adolesc Psychiatry. In press
31. Cantwell DP, Baker L. Attention deficit disorder with and without hyperactivity: a review and comparison of matched groups. J Am Acad Child Adolesc Psychiatry 1992;31:432-438
32. Barkley RA, DuPaul GJ, McMurray MB. Comprehensive evaluation of attention deficit disorder with and without hyperactivity as defined by research criteria. J Consult Clin Psychol 1990;58:775-798
33. Hart E, Lahey B, Loeber R, et al. Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study. J Abnorm Child Psychol 1995;23:729-749
34. Bird HR, Canino G, Rubio-Stipec M, et al. Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico. Arch Gen Psychiatry 1988;45:1120-1126
35. Anderson JC, Williams S, McGee R, et al. DSM-III disorders in preadolescent children: prevalence in a large sample from the general population. Arch Gen Psychiatry 1987;44:69-76
36. McConaughy S, Achenbach T. Comorbidity of empirically based syndromes in matched general population and clinical samples. J Child Psychol Psychiatry 1994;35:1141-1157
37. Boyd JH, Burke JD, Gruenberg E, et al. Exclusion criteria of DSM-III: a study of co-occurrence of hierarchy-free syndromes. Arch Gen Psychiatry 1984;41:983-989
38. Kessler R, McGonagle K, Zhao S, et al. Lifetime and 12 month prevalence of DSM-III-R psychiatric disorders in the United States: results from the national comorbidity survey. Arch Gen Psychiatry 1994;51:8-19
39. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991;148:564-577
40. Angold A, Costello EJ. Depressive comorbidity in children and adolescents: empirical, theoretical and methodological issues. Am J Psychiatry 1993;150:1779-1791
41. Faraone SV, Biederman J. Do ADHD and major depression share familial risk factors? J Nerv Ment Dis. In press
42. Wozniak J, Biederman J, Kiely K, et al. Mania-like symptoms suggestive of childhood onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry 1995;34:867-876
43. West S, McElroy S, Strakowski S, et al. Attention deficit hyperactivity disorder in adolescent mania. Am J Psychiatry 1995;152:271-274
44. Geller B, Sun K, Zimmerman B, et al. Complex and rapid-cycling in bipolar children and adolescents: a preliminary study. J Affect Disord 1995; 34:259-268
45. Butler FS, Arredondo DE, McCloskey V. Affective comorbidity in children and adolescents with attention deficit hyperactivity disorder. Ann Clin Psychiatry 1995;7:51-55
46. Winokur G, Coryell W, Endicott J, et al. Further distinctions between manic-depressive illness (bipolar disorder) and primary depressive disorder (unipolar depression). Am J Psychiatry 1993;150:1176-1181
47. Faraone SV, Biederman J, Mennin D, et al. Attention deficit hyperactivity disorder with bipolar disorder: a familial subtype? J Am Acad Child Adolesc Psychiatry. 1997;36:1378-1387
48. Biederman J, Faraone SV, Spencer T, et al. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res 1994; 53:13-29
49. Biederman J, Faraone SV, Spencer T, et al. Patterns of psychiatric comorbidity, cognition and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:1792-1798
50. Blazer D, Kessler R, McGonagle K, et al. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 1994;151:979-986
51. Lowe TL, Cohen DJ. Mania in childhood and adolescence. In: Belmaker RH, van Praag HM, eds. Mania: An Evolving Concept. Jamaica, NY: SP Medical & Scientific Books; 1980:111-117
52. Potter RL. Manic-depressive variant syndrome of childhood. Diagnostic and therapeutic considerations. Clin Pediatr 1983;22:495-499
53. Poznanski E, Israel M, Grossman J. Hypomania in a four-year-old. J Am Acad Child Adolesc Psychiatry 1984;23:105-110
54. Reiss AL. Developmental manifestations in a boy with prepubertal bipolar disorder. J Clin Psychiatry 1985;46:441-443
55. Thompson R, Schindler F. Embryonic mania. Child Psychiatry Hum Dev 1976;6:149-154
56. Sadler W. Juvenile manic activity. Nervous Child 1952;9:363-368
57. Wozniak J, Biederman J, Mundy E, et al. A pilot family study of childhood-onset mania. J Am Acad Child Adolesc Psychiatry 1995;34:1577-1583
58. Biederman J, Faraone SV, Mick E, et al. Attention deficit hyperactivity disorder and juvenile mania: an overlooked comorbidity? J Am Acad Child Adolesc Psychiatry 1996;35:997-1008
59. Morrison JR, Stewart MA. A family study of the hyperactive child syndrome. Biol Psychiatry 1971;3:189-195
60. Cantwell DP. Psychiatric illness in the families of hyperactive children. Arch Gen Psychiatry 1972;27:414-417
61. Faraone S, Biederman J. Genetics of attention-deficit hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America 1994;3: 285-302
62. Welner Z, Welner A, Stewart M, et al. A controlled study of siblings of hyperactive children. J Nerv Ment Dis 1977;165:110-117
63. Faraone S, Biederman J, Lehman BK, et al. Evidence for the independent familial transmission of attention deficit hyperactivity disorder and learning disabilities: results from a family genetic study. Am J Psychiatry 1993;150:891-895
64. Faraone SV, Biederman J, Lehman BK, et al. Intellectual performance and school failure in children with attention deficit hyperactivity disorder and in their siblings. J Abnorm Psychol 1993;102:616-623
65. Lopez RE. Hyperactivity in twins. Canadian Psychiatric Association Journal 1965;10:421-426
66. Gillis JJ, Gilger JW, Pennington BF, et al. Attention deficit disorder in reading-disabled twins: evidence for a genetic etiology. J Abnorm Child Psychol 1992;20:303-315
67. Stevenson J, Pennington BF, Gilger JW, et al. Hyperactivity and spelling disability: testing for shared genetic aetiology. J Child Psychol Psychiatry 1993;34:1137-1152
68. Waldeman ID, Levy F, Hay DA. Quantitative genetic analysis of DSM-III-R attention deficit hyperactivity disorder in an Australian twin sample. Presented at the annual conference of the Behavior Genetics Association; 1994; Barcelona, Spain
69. Cantwell DP. Genetics of hyperactivity. J Child Psychol Psychiatry 1975;16:261-264
70. Morrison JR, Stewart MA. The psychiatric status of the legal families of adopted hyperactive children. Arch Gen Psychiatry 1973;28:888-891
71. Eaves L, Silberg J, Hewitt J, et al. Genes, personality, and psychopathology: a latent class analysis of liability to symptoms of attention-deficit hyperactivity disorder in twins. In: Plomin R, McLearn G, eds. Nature, Nurture and Psychology. Washington, DC: American Psychological Association; 1993:285-306
72. Hess EJ, Rogan PK, Domoto M, et al. Absence of linkage of apparently single gene mediated ADHD with the human syntenic region of the mouse mutant Coloboma. Am J Med Genet 1995;60:573-579
73. Hauser P, Zametkin A, Martinez P, et al. Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med 1993;328:997-1001
74. Comings DE, Comings BG, Muhleman D, et al. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA 1991;266: 1793-1800
75. Cook EH, Stein MA, Krasowski MD, et al. Association of attention deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995;56: 993-998
76. LaHoste GJ, Swanson JM, Wigal SB, et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Molecular Psychiatry 1996;1:128-131
77. Faraone S, Kremen W, Lyons M, et al. Diagnostic accuracy and linkage analysis: how useful are schizophrenia spectrum phenotypes? Am J Psychiatry 1995;152:1286-1290
78. Biederman J, Faraone SV, Keenan K, et al. Evidence of familial association between attention deficit disorder and major affective disorders. Arch Gen Psychiatry 1991;48:633-642
79. Faraone SV, Biederman J, Keenan K, et al. Separation of DSM-III attention deficit disorder and conduct disorder: evidence from a family-genetic study of American child psychiatric patients. Psychol Med 1991;21:109-121
80. Pauls DL, Towbin KE, Leckman JF, et al. Gilles de la Tourette's Syndrome and obsessive-compulsive disorder: evidence supporting a genetic relationship. Arch Gen Psychiatry 1986;43:1180-1182
81. Reich T, Rice J, Cloninger CR, et al. The use of multiple thresholds and segregation analysis in analyzing the phenotypic heterogeneity of multifactorial traits. Ann Hum Genet 1979;42:371-389
82. Biederman J, Faraone SV, Keenan K, et al. Familial association between attention deficit disorder and anxiety disorders. Am J Psychiatry 1991;148: 251-256
83. Gaub M, Carlson C. Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry. In press
84. Barkley R. Hyperactive girls and boys: stimulant drug effects on mother-child interactions. J Child Psychol Psychiatry 1989;30:379-390
85. Pelham WE, Walker JL, Sturges J, et al. Comparative effects of methylphenidate on ADD girls and ADD boys. J Am Acad Child Adolesc Psychiatry 1989;28:773-776
86. Faraone SV, Biederman J, Keenan K, et al. A family-genetic study of girls with DSM-III attention deficit disorder. Am J Psychiatry 1991;148: 112-117
87. Weiss G, Minde K, Werry JS, et al. Studies on the hyperactive child, VIII: five-year follow-up. Arch Gen Psychiatry 1971;24:409-414
88. Cohen NJ, Weiss G, Minde K. Cognitive styles in adolescents previously diagnosed as hyperactive. Journal of Child Psychology 1972;13:203-209
89. Minde K, Weiss G, Mendelson N. A five year follow-up study of 91 hyperactive school children. J Am Acad Child Psychiatry 1972;11:595-610
90. Hoy E, Weiss G, Minde K, et al. The hyperactive child at adolescence: cognitive, emotional and social functioning. J Abnorm Child Psychol 1978;6: 311-324
91. Hechtman L, Weiss G, Perlman T, et al. Hyperactives as young adults: initial predictors of adult outcome. J Am Acad Child Psychiatry 1984;23: 250-260
92. Loney J, Kramer J, Milich RS. The hyperactive child grows up: predictors of symptoms, delinquency and achievement at follow-up. In: Gadow KD, Loney J, eds. Psychosocial Aspects of Drug Treatment for Hyperactivity. Boulder, Colo: Westview Press; 1981:381-416
93. Satterfield JH, Hoppe CM, Schell AM. A prospective study of delinquency in 110 adolescent boys with attention deficit disorder and 88 normal adolescent boys. Am J Psychiatry 1982;139:795-798
94. August GJ, Stewart MA, Holmes CS. A four-year follow-up of hyperactive boys with and without conduct disorder. Br J Psychiatry 1983;143: 192-198
95. Mannuzza S, Klein RG, Horowitz-Konig P, et al. Hyperactive boys almost grown up, IV: criminality and its relationship to psychiatric status. Arch Gen Psychiatry 1989;46:1073-1079
96. Mannuzza S, Klein RG, Addalli KA. Young adult mental status of hyperactive boys and their brothers: a prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1991;30:743-751
97. Barkley RA, Fischer M, Edelbrock CS, et al. The adolescent outcome of hyperactive children diagnosed by research criteria, I: an 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1990;29: 546-557
98. Hechtman L, Weiss G. Controlled prospective fifteen year follow-up of hyperactives as adults: non-medical drug and alcohol use and anti-social behaviour. Can J Psychiatry 1986;31:557-567
99. Taylor E, Sandberg S, Thorley G, et al. The Epidemiology of Childhood Hyperactivity. New York, NY: Oxford University Press; 1991
100. Biederman J, Faraone SV, Milberger S, et al. Predictors of persistence and remission of ADHD: results from a four year prospective follow-up study of ADHD children. J Am Acad Child Adolesc Psychiatry 1996;35: 343-351
101. Klein RG, Mannuzza S. Long-term outcome of hyperactive children: a review. J Am Acad Child Adolesc Psychiatry 1991;30:383-387
102. Weiss G, Hechtman LT. Hyperactive Children Grown Up. New York, NY: Guilford Press; 1986
103. Thorley G. Review of follow-up and follow-back studies of childhood hyperactivity. Psychol Bull 1984;96:116-132
104. Hill J, Schoener E. Age-dependent decline of attention deficit hyperactivity disorder. Am J Psychiatry 1996;153:1143-1147
105. Barkley R. Age dependent decline in ADHD: true recovery or statistical illusion? The ADHD Report 1997;5:1-5
106. Schaffer D. Attention deficit hyperactivity disorder in adults [editorial]. Am J Psychiatry 1994;151:633-638
107. Seidman LJ, Biederman J, Weber W, et al. Neuropsychological functioning in adults with ADHD. Biol Psychiatry. In press
108. Barkley RA. A review of stimulant drug research with hyperactive children. J Child Psychol Psychiatry 1977;18:137-165
109. Gittelman R. Childhood disorders. In: Klein D, Quitkin F, Rifkin A, et al, eds. Drug Treatment of Adult and Child Psychiatric Disorders. Baltimore, Md: Williams & Wilkins; 1980:576-756
110. Spencer TJ, Biederman J, Wilens T, et al. Pharmacotherapy of ADHD across the lifecycle: a literature review. J Am Acad Child Adolesc Psychiatry 1996;35:409-432
111. Elia J, Borcherding BG, Rapoport JL, et al. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders? Psychiatry Res 1991;36:141-155
112. Barkley RA. The effects of methylphenidate on the interactions of preschool ADHD children with their mothers. J Am Acad Child Adolesc Psychiatry 1988;27:336-341
113. Barkley RA, Karlsson J, Strzelecki E, et al. Effects of age and Ritalin dosage on mother-child interactions of hyperactive children. J Consult Clin Psychol 1984;52:750-758
114. Conners CK. Controlled trial of methylphenidate in preschool children with minimal brain dysfunction. Int J Ment Health 1975;4:61-74
115. Mayes S, Crites D, Bixler E, et al. Methylphenidate and ADHD: influence of age, IQ and neurodevelopmental status. Develop Med Child Neurol 1994;36:1099-1107
116. Schleifer N, Weiss G, Cohen N, et al. Hyperactivity in preschoolers and the effect of methylphenidate. Am J Orthopsychiatry 1975;45:38-50
117. Varley CK. Effects of methylphenidate in adolescents with attention deficit disorder. J Am Acad Child Psychiatry 1983;22:351-354
118. Evans SW, Pelham WE. Psychostimulant effects on academic and behavioral measures for ADHD junior high school students in a lecture format classroom. J Abnorm Child Psychol 1991;19:537-552
119. Brown RT, Sexson SB. A controlled trial of methylphenidate in black adolescents. Clin Pediatr 1988;27:74-81
120. Coons HW, Klorman R, Borgstedt AD. Effects of methylphenidate on adolescents with a childhood history of ADHD, II: information processing. J Am Acad Child Adolesc Psychiatry 1987;26:368-374
121. Klorman R, Coons HW, Borgstedt AD. Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder, I: clinical findings. J Am Acad Child Adolesc Psychiatry 1987;26:363-367. Correction 1987;26:820
122. Lerer RJ, Lerer MP. Responses of adolescents with minimal brain dysfunction to methylphenidate. Journal of Learning Disabilities 1977;10: 223-228
123. MacKay MC, Beck L, Taylor R. Methylphenidate for adolescents with minimal brain dysfunction. New York State Journal of Medicine 1973;73: 550-554
124. Safer DJ, Allen RP. Stimulant drug treatment of hyperactive adolescents. Dis Nerv Syst 1975;454-457
125. Wood DR, Reimherr FW, Wender PH, et al. Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. Arch Gen Psychiatry 1976;33:1453-1460
126. Wender PH, Reimherr FW, Wood DR, et al. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry 1985;142:547-552
127. Mattes JA, Boswell L, Oliver H. Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 1984;41: 1059-1063
128. Gualtieri CT, Ondrusek MG, Finley C. Attention deficit disorders in adults. Clin Neuropharmacol 1985;8:343-356
129. Wender PH, Reimherr FW, Wood DR. Attention deficit disorder ("minimal brain dysfunction") in adults: a replication study of diagnosis and drug treatment. Arch Gen Psychiatry 1981;38:449-456
130. Spencer T, Wilens TE, Biederman J, et al. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention deficit hyperactivity. Arch Gen Psychiatry 1995;52:434-443
131. Safer DJ, Allen RP, Barr E. Depression of growth in hyperactive children on stimulant drugs. N Engl J Med 1972;287:217-220
132. Mattes JA, Gittelman R. Growth of hyperactive children on maintenance regimen of methylphenidate. Arch Gen Psychiatry 1983;40:317-321
133. Lowe TL, Cohen DJ, Detlor J. Stimulant medications precipitate Tourette's syndrome. JAMA 1982;247:1168-1169
134. Jaffe S. Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD. J Am Acad Child Adolesc Psychiatry 1991;773-775
135. Johnston C, Pelham WE, Hoza J, et al. Psychostimulant rebound in attention deficit disordered boys. J Am Acad Child Adolesc Psychiatry 1988; 27:806-810
136. Satterfield JH, Cantwell DP, Schell A, et al. Growth of hyperactive children treated with methylphenidate. Arch Gen Psychiatry 1979;36: 212-217
137. Gross M. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine. J Pediatr 1976;58:423-431
138. Gittelman R, Mannuzza S. Hyperactive boys almost grown up, III: methylphenidate effects on ultimate height. Arch Gen Psychiatry 1988;45: 1131-1134
139. Spencer T, Biederman J, Harding M, et al. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry 1996;35:1460-1469
140. Gadow K, Nolan E, Sverd J. Methylphenidate in hyperactive boys with comorbid tic disorder, II: short-term behavioral effects in school settings. J Am Acad Child Adolesc Psychiatry 1992;31:462-471
141. Comings DE, Comings BG. Tourette's syndrome and attention deficit disorder. In: Cohen DJ, Bruun RD, Leckman JF, eds. Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment. New York, NY: John Wiley & Sons; 1988:119-136
142. Gadow K, Sverd J, Sprafkin J, et al. Efficacy of methylphenidate for ADHD in children with tic disorder. Arch Gen Psychiatry 1995;52: 444-455
143. Biederman J, Wilens T, Mick E, et al. Psychoactive substance use disorder in adults with attention deficit hyperactivity disorder: effects of ADHD and psychiatric comorbidity. Am J Psychiatry 1995;152: 1652-1658
144. Biederman J, Baldessarini RJ, Wright V, et al. A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder, I: efficacy. J Am Acad Child Adolesc Psychiatry 1989;28:777-784
145. Biederman J, Gastfriend DR, Jellinek MS. Desipramine in the treatment of children with attention deficit disorder. J Clin Psychopharmacol 1986;6:359-363
146. Gastfriend DR, Biederman J, Jellinek MS. Desipramine in the treatment of attention deficit disorder in adolescents. Psychopharmacol Bull 1985; 21:144-145
147. Wilens TE, Biederman J, Geist DE, et al. Nortriptyline in the treatment of attention deficit hyperactivity disorder: a chart review of 58 cases. J Am Acad Child Adolesc Psychiatry 1993;32:343-349
148. Wilens TE, Biederman J, Prince J, et al. Six week, double blind, placebo controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 1996;153:1147-1153
149. Quinn PO, Rapoport JL. One-year follow-up of hyperactive boys treated with imipramine or methylphenidate. Am J Psychiatry 1975;132: 241-245
150. Rapport M, Carlson G, Kelly K, et al. Methylphenidate and desipramine in hospitalized children, I: separate and combined effects on cognitive function. J Am Acad Child Adolesc Psychiatry 1993;32:333-342
151. Gualtieri CT, Evans RW. Motor performance in hyperactive children treated with imipramine. Percept Mot Skills 1988;66:763-769
152. Werry J. Imipramine and methylphenidate in hyperactive children. J Child Psychol Psychiatry 1980;21:27-35
153. Abramowicz M, ed. Med Lett Drugs Ther 1990;32:37-40
154. Biederman J, Thisted R, Greenhill L, et al. Estimation of the association between desipramine and the risk for sudden death in 5-to 14-year-old children. J Clin Psychiatry 1995;56:87-93
155. Biederman J, Baldessarini R, Goldblatt A, et al. A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic finding in children and adolescents treated with desipramine. J Am Acad Child Adolesc Psychiatry 1993;32:805-813
156. Casat CD, Pleasants DZ, Schroeder DH, et al. Bupropion in children with attention deficit disorder. Psychopharmacol Bull 1989;25:198-201
157. Casat CD, Pleasants DZ, Van Wyck Fleet J. A double-blind trial of bupropion in children with attention deficit disorder. Psychopharmacol Bull 1987;23:120-122
158. Conners C, Casat C, Gualtieri C, et al. Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 1996;35:1314-1321
159. Barrickman L, Perry P, Allen A, et al. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995;34:649-657
160. Wender PH, Reimherr FW. Bupropion treatment of attention-deficit hyperactivity disorder in adults. Am J Psychiatry 1990;147:1018-1020
161. Jankovic J. Deprenyl in attention deficit associated with Tourette's syndrome. Arch Neurol 1993;50:286-288
162. Zametkin A, Rapoport JL, Murphy DL, et al. Treatment of hyperactive children with monoamine oxidase inhibitors, I: clinical efficacy. Arch Gen Psychiatry 1985;42:962-966
163. Wender PH, Wood DR, Reimherr FW, et al. An open trial of pargyline in the treatment of attention deficit disorder, residual type. Psychiatry Res 1983;9:329-336
164. Wender PH, Wood DR, Reimherr FW. Pharmacological treatment of attention deficit disorder, residual type (ADDRT, "minimal brain dysfunction," "hyperactivity") in adults. Psychopharmacol Bull 1985;21: 222-232
165. Barrickman L, Noyes R, Kuperman S, et al. Treatment of ADHD with fluoxetine: a preliminary trial. J Am Acad Child Adolesc Psychiatry 1991; 30:762-767
166. Adler L, Resnick S, Kunz M, et al. Open-label trial of venlafaxine in attention deficit disorder. In: New Clinical Drug Evaluation Unit Program; 1995; Orlando, Fla
167. Reimherr F, Hedges D, Strong R, et al. An open-trial of venlafaxine in adult patients with attention deficit hyperactivity disorder. In: New Clinical Drug Evaluation Unit Program; 1995; Orlando, Fla
168. Hunt RD. Treatment effects of oral and transdermal clonidine in relation to methylphenidate: an open pilot study in ADD-H. Psychopharmacol Bull 1987;23:111-114
169. Steingard R, Biederman J, Spencer T, et al. Comparison of clonidine response in the treatment of attention deficit hyperactivity disorder with and without comorbid tic disorders. J Am Acad Child Adolesc Psychiatry 1993;32:350-353
170. Hunt RD, Minderaa RB, Cohen DJ. Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Psychiatry 1985;24: 617-629
171. Gunning B. A Controlled Trial of Clonidine in Hyperkinetic Children. Rotterdam, The Netherlands: Academic Hospital Rotterdam-Sophia Children's Hospital; 1992. Thesis
172. Hunt R, Arnsten A, Asbell M. An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995;34:50-54
173. Hinshaw S, Buhrmester D, Heller T. Anger control in response to verbal provocation: effects of stimulant medication for boys with ADHD. J Abnorm Child Psychol 1989;17:393-407
174. Klorman R, Brumaghim JT, Salzman LF, et al. Comparative effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features. Psychopharmacol Bull 1989; 25:109-113
175. Klorman R, Brumaghim JT, Salzman LF, et al. Effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features. J Abnorm Psychol 1988;97:413-422
176. Barkley RA, McMurray MB, Edelbrock CS, et al. The response of aggressive and nonaggressive ADHD children to two doses of methylphenidate. J Am Acad Child Adolesc Psychiatry 1989;28:873-881
177. Winsberg BG, Bialer I, Kupietz S, et al. Effects of imipramine and dextroamphetamine on behavior of neuropsychiatrically impaired children. Am J Psychiatry 1972;128:1425-1431
178. Winsberg BG, Press M, Bialer I, et al. Dextroamphetamine and methylphenidate in the treatment of hyperactive/aggressive children. Pediatrics 1974;53:236-241
179. Taylor E, Schachar R, Thorley G, et al. Which boys respond to stimulant medication? a controlled trial of methylphenidate in boys with disruptive behaviour. Psychol Med 1987;17:121-143
180. Whalen C, Henker B, Swanson J, et al. Natural social behaviors in hyperactive children: dose effects of methylphenidate. J Consult Clin Psychol 1987;55:187-193
181. Pliszka SR. Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry 1989;28:882-887
182. Pelham W, Greenslade K, Vodde-Hamilton M, et al. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics 1990;86:226-237
183. Gadow KD, Nolan EE, Sverd J, et al. Methylphenidate in aggressive-hyperactive boys, I: effects on peer aggression in public school settings. J Am Acad Child Adolesc Psychiatry 1990;29:710-718
184. Murphy D, Pelham W, Lang A. Aggression in boys with attention deficit-hyperactivity disorder: methylphenidate effects on naturalistically observed aggression, response to provocation, and social information processing. J Abnorm Child Psychol 1992;20:451-466
185. Amery B, Minichiello M, Brown G. Aggression in hyperactive boys: response to d-amphetamine. J Am Acad Child Psychiatry 1984;23:291-294
186. Hinshaw S, Heller T, McHale J. Covert antisocial behavior in boys with attention-deficit hyperactivity disorder: external validation and effects of methylphenidate. J Consult Clin Psychol 1992;60:274-281
187. Livingston R, Dykman R, Ackerman P. Psychiatric comorbidity and response to two doses of methylphenidate in children with attention deficit disorder. J Child Adolesc Psychopharmacol 1992;2:115-122
188. Cunningham C, Siegel L, Offord D. A dose-response analysis of the effects of methylphenidate on the peer interactions and simulated classroom performance of ADD children with and without conduct problems. J Child Psychol Psychiatry 1991;32:439-452
189. Klorman R, Brumaghim J, Fitzpatrick P, et al. Clinical and cognitive effects of methylphenidate on children with attention deficit disorder as a function of aggression/oppositionality and age. J Abnorm Psychol 1994;103:206-221
190. Kaplan SL, Busner J, Kupietz S, et al. Effects of methylphenidate on adolescents with aggressive conduct disorder and ADDH: a preliminary report. J Am Acad Child Adolesc Psychiatry 1990;29:719-723
191. Simeon JG, Ferguson HB, Van Wyck Fleet J. Bupropion effects in attention deficit and conduct disorders. Can J Psychiatry 1986;31:581-585
192. Biederman J, Baldessarini RJ, Wright V, et al. A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder, III: lack of impact of comorbidity and family history factors on clinical
193. Sverd J, Gadow K, Nolan E, et al. Methylphenidate in hyperactive boys with comorbid tic disorder, I: clinic evaluations. Adv Neurol 1992;58: 271-281
194. Sverd J, Gadow KD, Paolicelli LM. Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1989;28:574-579
195. Denckla MB, Bemporad JR, MacKay MC. Tics following methylphenidate administration: a report of 20 cases. JAMA 1976;235:1349-1351
196. Golden G. Stimulant medication in Tourette's Syndrome [letter]. JAMA 1982;248:1063
197. Caine E, Ludlow C, Polinsky R, et al. Provocative drug testing in Tourette's syndrome: d- and 1-amphetamine and haloperidol. J Am Acad Child Psychiatry 1984;23:147-152
198. Erenberg G, Cruse RP, Rothner AD. Gilles de la Tourette's syndrome: effects of stimulant drugs. Neurology 1985;35:1346-1348
199. Price AR, Leckman JF, Pauls DL, et al. Gilles de la Tourette's syndrome: tics and central nervous system stimulants in twins and nontwins. Neurology 1986;36:232-237
200. Konkol R, Fischer M, Newby R. Double-blind, placebo-controlled stimulant trial in children with Tourette's syndrome and ADHD [abstract]. Ann Neurol 1990;28:424
201. Erenberg G. Stimulant medication in Tourette's Syndrome [letter]. JAMA 1982;248:1062
202. Shapiro AK, Shapiro E. Do stimulants provoke, cause, or exacerbate tics and Tourette syndrome? Compr Psychiatry 1981;22:265-273
203. Golden G. The effect of central nervous system stimulants on Tourette Syndrome. Ann Neurol 1977;2:69-70
204. Swanson J, Kinsbourne M, Roberts W, et al. Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics 1978;61:21-24
205. Voelker SL, Lachar D, Gdowski LL. The personality inventory for children and response to methylphenidate: preliminary evidence for predictive validity. J Pediatr Psychol 1983;8:161-169
206. DuPaul G, Barkley R, McMurray M. Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. J Am Acad Child Adolesc Psychiatry 1994;33:894-903
207. Tannock R, Ickowicz A, Schachar R. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 1995;34:886-896
208. Garfinkel BD, Wender PH, Sloman L, et al. Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children. J Am Acad Child Adolesc Psychiatry 1983;22:343-348
209. Wozniak J, Biederman J. A pharmacological approach to the quagmire of comorbidity in juvenile mania. J Am Acad Child Adolesc Psychiatry 1996;35:826-828
210. Wilens T, Spencer T, Biederman J, et al. Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry 1994;34:110-112